Background: The controversy over the relationship between symptoms of anxiety and depression is an enduring issue. Various models have been proposed to explain this relationship. We explored the following research questions. First, using exploratory factor analysis (EFA), will the symptoms that define anxiety and depression (as in the Hopkins Symptom Checklist 25, HSCL-25) appear together in 1 factor, or are they separable into the hypothesized dimensions of the disorders? Second, using confirmatory factor analysis, how will the structural integrity of the resulting factors compare with those of the various models that have been proposed to explain the relationship between the symptoms of anxiety and depression? This issue has not been investigated in an Arab setting. Method: Participants (n = 624) were Kuwaiti national college students, who completed the HSCL-25 in class. EFA was done by principal axis factoring. Seven models were generated for comparison in confirmatory factor analysis, using 8 ‘fit’ indices in Analysis of Moment Structures, version 16. Results: The 5 factors from EFA were similar in construct to the subscales of the Mood and Anxiety Symptom Questionnaire, on which the tripartite model of anxiety and depression was validated (‘core anxiety’, ‘core depression’, ‘general distress mixed’, ‘general distress anxiety’, ‘general distress depression’). The hierarchical bifactor model and the dimensional model characterized by the correlation of these factors were best at meeting the fit indices, followed by the correlated 2-factor anxiety/depression model. In line with theory, the correlation between the specific anxiety/depression factors was lower than that between each of them and the general distress mixed factor; and there was no significant gender difference in the summed score for core depression. Conclusion: The findings support the impression that, although the core symptoms of anxiety are separable from the core symptoms of depression, there is an overlapping set of symptoms which contribute to the experience of comorbidity. The relationship between symptoms of anxiety and depression probably has dimensional and hierarchical elements. The findings broaden the evidence base of the cross-cultural validity of the tripartite model.

Keywords:
Anxiety, Depression, Hopkins Symptom Checklist 25
1.
Kessler RC: Psychiatric epidemiology: challenges and opportunities. Int Rev Psychiatry 2007;19:509–521.
2.
Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, et al: Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry 2007;64:651–660.
3.
Barlow DH, Campbell LA: Mixed anxiety-depression and its implications for models of mood and anxiety disorders. Compr Psychiatry 2000;41(suppl 1):55–60.
4.
Goldberg D: Towards DSM-V: the relationship between generalized anxiety disorder and major depressive episode. Psychol Med 2008;38:1671–1675.
5.
Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC: Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol 2000;15:319–328.
6.
Watson D, O’Hara MW, Stuart S: Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depress Anxiety 2008;25:282–288.
7.
Goldberg DP, Krueger RF, Andrews G, Hobbs MJ: Emotional disorders: cluster 4 of the proposed meta-structure for DSM-V and ICD-11. Psychol Med 2009;39:2043–2059.
8.
Krueger RF, Watson D, Barlow DH: Introduction to the special section: toward a dimensionally based taxonomy of psychopathology. J Abnorm Psychol 2005;114:491–493.
9.
Hale WW 3rd, Raaijmakers QAW, Muris P, van Hoof A, Meeus WHJ: One factor or two parallel processes? Comorbidity and development of adolescent anxiety and depressive disorder symptoms. J Child Psychol Psychiatry 2009;50:1218.
10.
Laurent J, Ettelson R: An examination of the tripartite model of anxiety and depression and its application to youth. Clin Child Fam Psychol Rev 2001;4:209–230.
11.
Olino TM, Klein DN, Lewinsohn PM, Rohde P, Seeley JR: Longitudinal associations between depressive and anxiety disorders: a comparison of two trait models. Psychol Med 2008;38:353–363.
12.
Clark LA, Watson D: Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991;100:316–336.
13.
Patrick CJ, Hicks BM, Nichol PE, Krueger RF: A bifactor approach to modeling the structure of the psychopathy checklist-revised. J Pers Disord 2007;21:118–141.
14.
Byrne BM: Factor analytic models: viewing the structure of the assessment instrument from three perspectives. J Pers Assess 2005;85:17–32.
15.
Simms LJ, Gros DF, Watson D, O’Hara MW: Parsing the general and specific components of depression and anxiety with bifactor modeling. Depress Anxiety 2008;25:E34–E46.
16.
Joiner TE Jr, Blalock JA: Gender differences in depression: the role of anxiety and generalized negative affect. Sex Roles 1995;33:91–108.
17.
Watson D, Weber K, Assenheimer JS, Clark LA, Strauss ME, McCormick RA: Testing a tripartite model. 1. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales. J Abnorm Psychol 1995;104:3–14.
18.
Watson D, Clark LA, Weber K, Assenheimer JS, Strauss ME, McCormick RA: Testing a tripartite model. 2. Exploring the symptom structure of anxiety and depression in student, adult, and patient samples. J Abnorm Psychol 1995;104:15–25.
19.
Brown TA, Chorpita BF, Korotitsch W, Barlow DH: Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther 1997;35:79–89.
20.
Crawford JR, Henry JD: The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol 2003;42(pt 2):111–131.
21.
Enns MW, Cox BJ, Parker JD, Guertin JE: Confirmatory factor analysis of the Beck Anxiety and Depression Inventories in patients with major depression. J Affect Disord 1998;47:195–200.
22.
Tully PJ, Zajac IT, Venning AJ: The structure of anxiety and depression in a normative sample of younger and older Australian adolescents. J Abnorm Child Psychol 2009;37:717–726.
23.
Steer RA, Clark DA, Ranieri WF: Symptom dimensions of the SCL-90-R: a test of the tripartite model of anxiety and depression. J Pers Assess 1994;62:525–536.
24.
Steer RA, Clark DA, Beck AT, Ranieri WF: Common and specific dimensions of self-reported anxiety and depression: a replication. J Abnorm Psychol 1995;104:542–545.
25.
Steer RA, Clark DA, Beck AT, Ranieri WF: Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther 1999;37:183–190.
26.
Rodgers J, Martin CR, Morse RC, Kendell K, Verrill M: An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes 2005;3:41.
27.
Joiner TE Jr, Catanzaro SJ, Laurent J: Tripartite structure of positive and negative affect, depression and anxiety in child and adolescent psychiatric inpatients. J Abnorm Psychol 1996;105:401–409.
28.
Anderson ER, Hope DA: A review of the tripartite model for understanding the link between anxiety and depression in youth. Clin Psychol Rev 2008;28:275–287.
29.
Boschen MJ, Oei TPS: Factor structure of the Mood and Anxiety Symptom Questionnaire does not generalize to an anxious/depressed sample. Aust NZ J Psychiatry 2006;40:1016–1024.
30.
Buckby JA, Yung AR, Cosgrave EM, Cotton SM: Distinguishing between anxiety and depression using the Mood and Anxiety Symptoms Questionnaire (MASQ). Br J Clin Psychol 2007;46(pt 2):235–239.
31.
Buckby JA, Cotton SM, Cosgrave EM, Killackey EJ, Yung AR: A factor analytic investigation of the Tripartite model of affect in a clinical sample of young Australians. BMC Psychiatry 2008;8:79.
32.
Greaves-Lord K, Ferdinand RF, Sondeijker FE, Dietrich A, Oldehinkel AJ, Rosmalen JG, et al: Testing the tripartite model in young adolescents: is hyperarousal specific for anxiety and not depression? J Affect Disord 2007;102:55–63.
33.
Hughes AA, Heimberg RG, Coles ME, Gibb BE, Liebowitz MR, Schneier FR: Relations of the factors of the tripartite model of anxiety and depression to types of social anxiety. Behav Res Ther 2006;44:1629–1641.
34.
Feldman LA: Distinguishing depression and anxiety in self-report: evidence from confirmatory factor analysis on nonclinical and clinical samples. J Consult Clin Psychol 1993;61:631–638.
35.
Means-Christensen AJ, Sherbourne CD, Roy-Byrne PP, Schulman MC, Wu J, Dugdale DC, et al: In search of mixed anxiety-depressive disorder: a primary care study. Depress Anxiety 2006;23:183–189.
36.
Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, et al: Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother 2002;75(pt 2):165–176.
37.
Clark DA, Beck AT, Beck JS: Symptom differences in major depression, dysthymia, panic disorder, and generalized anxiety disorder. Am J Psychiatry 1994;151:205–209.
38.
Kiernan G, Laurent J, Joiner TE Jr, Catanzaro SJ, MacLachlan M: Cross-cultural examination of the tripartite model with children: data from the Barretstown studies. J Pers Assess 2001;77:359–379.
39.
Wang W, Lopez V, Thompson D, Martin CR: Structural ambiguity of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease. Health Qual Life Outcomes 2006;4:6.
40.
Yang J-W, Hong SD, Joung YS, Kim J-H: Validation study of tripartite model of anxiety and depression in children and adolescents: clinical sample from Korea. J Korean Med Sci 2006;21:1098–1102.
41.
Holzinger K, Swineford F: The bi-factor method. Psychometrika 1937;2:41–54.
42.
Cook KF, Kallen MA, Amtmann D: Having a fit: impact of number of items and distribution of data on traditional criteria for assessing IRT’s unidimensionality assumption. Qual Life Res 2009;18:447–460.
43.
Reise SP, Morizot J, Hays RD: The role of the bifactor model in resolving dimensionality issues in health outcome measures. Qual Life Res 2007;16(suppl 1):19–31.
44.
Toplak ME, Pitch A, Flora DB, Iwenofu L, Ghelani K, Jain U, Tannock R: The unity and diversity of inattention and hyperactivity/impulsivity in ADHD: evidence for a general factor with separable dimensions. J Abnorm Child Psychol 2009;37:1137–1150.
45.
Rao D, Choi SW, Victorson D, Bode R, Peterman A, Heinemann A, et al: Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI). Qual Life Res 2009;18:585–595.
46.
Yang FM, Jones RN: Measurement differences in depression: chronic health-related and socio-demographic effects in older Americans. Psychosom Med 2008;70:993–1004.
47.
Chen FF, West SG, Sousa KH: A comparison of bifactor and second-order models of quality of life. Multivariate Behav Res 2006;41:189–225.
48.
Gibbons RD, Hedeker DR: Full-information item bi-factor analysis. Psychometrika 1992;57:423–436.
49.
Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L: The Hopkins Symptom Checklist (HSCL): a self-report inventory. Behav Sci 1974;19:1–15.
50.
Nettelbladt P, Hansson L, Stefansson CG, Borgquist L, Nordström G: Test characteristics of the Hopkins Symptom Check List-25 (HSCL-25) in Sweden, using the Present State Examination (PSE-9) as a caseness criterion. Soc Psychiatry Psychiatr Epidemiol 1993;28:130–133.
51.
Sandanger I, Moum T, Ingebrigtsen G, Dalgard OS, Sørensen T, Bruusgaard D: Concordance between symptom screening and diagnostic procedure: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview. 1. Soc Psychiatry Psychiatr Epidemiol 1998;33:345–354.
52.
Veijola J, Jokelainen J, Läksy K, Kantojärvi L, Kokkonen P, Järvelin MR, et al: The Hopkins Symptom Checklist-25 in screening DSM-III-R axis-I disorders. Nord J Psychiatry 2003;57:119–123.
53.
Tinghög P, Carstensen J: Cross-cultural equivalence of HSCL-25 and WHO (ten) Wellbeing Index: findings from a population-based survey of immigrants and non-immigrants in Sweden. Community Ment Health J 2010;46:65–76.
54.
Roberts B, Damundu EY, Lomoro O, Sondorp E: Post-conflict mental health needs: a cross-sectional survey of trauma, depression and associated factors in Juba, Southern Sudan. BMC Psychiatry 2009;9:7.
55.
Bean T, Derluyn I, Eurelings-Bontekoe E, Broekaert E, Spinhoven P: Validation of the multiple language versions of the Hopkins Symptom Checklist-37 for refugee adolescents. Adolescence 2007;42:51–71.
56.
Sandanger I, Moum T, Ingebrigtsen G, Sørensen T, Dalgard OS, Bruusgaard D: The meaning and significance of caseness: the Hopkins Symptom Checklist-25 and the Composite International Diagnostic Interview. 2. Soc Psychiatry Psychiatr Epidemiol 1999;34:53–59.
57.
Al-Turkait FA, Ohaeri JU: Post-traumatic stress disorder among wives of Kuwaiti veterans of the first Gulf War. J Anxiety Disord 2008;22:18–31.
58.
Al-Turkait FA, Ohaeri JU: Prevalence and correlates of posttraumatic stress disorder among Kuwaiti military men according to level of involvement in the first Gulf War. Depress Anxiety 2008;25:932–941.
59.
Syed HR, Zachrisson HD, Dalgard OS, Dalen I, Ahlberg N: Concordance between Hopkins Symptom Checklist (HSCL-10) and Pakistan Anxiety and Depression Questionnaire (PADQ), in a rural self-motivated population in Pakistan. BMC Psychiatry 2008;8:59.
60.
Rodebaugh TL, Holaway RM, Heimberg RG: The factor structure and dimensional scoring of the generalized anxiety disorder questionnaire for DSM-IV. Assessment 2008;15:343–350.
61.
Beck AT, Steer RA, Brown GK: Manual for the Beck Depression Inventory, ed 2. San Antonio, Psychological Corporation, 1996.
62.
Arbuckle JL, Wothke W: AMOS 4.0 User’s Guide. Chicago, SmallWaters, 1999.
63.
Costello AB, Osborne JW: Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assess Res Eval 2005;10:7.
64.
Hooper D, Coughlan J, Mullen MR: Structural equation modelling: guidelines for determining model fit. Electron J Business Res Methods 2008;6:53–60.
65.
Enns MW, Cox BJ, Parker JDA, Guertin JE: Confirmatory factor analysis of the Beck Anxiety and Depression Inventories in patients with major depression. J Affect Disord 1998;47:195–200.
66.
Marsh HW, Hau K, Wen Z: In search of golden rules: comment on hypothesis-testing approaches to setting cutoff values for fit indexes and dangers in overgeneralizing Hu and Bentler’s (1999) findings. Struct Equ Modeling 2004;11:320–341.
67.
Ruscio AM, Lane M, Roy-Byrne P, Stang PE, Stein DJ, Wittchen HU, et al: Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication. Psychol Med 2005;35:1761–1772.
68.
Tyrer P: The case for cothymia: mixed anxiety and depression as a single diagnosis. Br J Psychiatry 2001;179:191–193.
69.
Lovibond SH, Lovibond PF: Manual for the Depression Anxiety Stress Scales, ed 2. Sydney, Psychology Foundation, 1995.
70.
Henry JD, Crawford JR: The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol 2005;44:227–239.
71.
Szabo M: The short version of the Depression Anxiety Stress Scales (DASS-21): factor structure in a young adolescent sample. J Adolesc 2010;33:1–8.
72.
Watson D: Differentiating the mood and anxiety disorders: a quadripartite model. Annu Rev Psychol 2009;5:221–247.
73.
Eid M, Lischetzke T, Nussbeck F, Trierweiler L: Separating trait effects from trait-specific method effects in multitrait-multimethod models: a multiple indicator CT-C(M-1) model. Psychol Methods 2003;8:38–60.
74.
Zinbarg RE, Barlow DH: Structure of anxiety and the anxiety disorders: a hierarchical model. J Abnorm Psychol 1996;105:181–193.
75.
Brown TA, Chorpita BF, Barlow DH: Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect and autonomic arousal. J Abnorm Psychol 1998;107:179–192.
76.
Krueger RF, Piasecki TM: Toward a dimensional and psychometrically informed approach to conceptualizing psychopathology. Behav Res Ther 2002;40:485–499.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.